Inhalation products
Product Description
Siegfried AG
-
CH
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Categories
Specifications
Siegfried AG
-
CH
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
More Products from Siegfried AG (4)
-
Product API portfolio
Siegfried offers a broad portfolio of active pharmaceutical ingredients including controlled substances, focused on anesthetics, analgesics, decongestants, addiction treatment, and a variety of other therapeutic indications. In addition, we offer pharma grade caffeine for use in pharmaceutical and nutritio... -
Product Exclusive synthesis
We are experts in process development and manufacturing of exclusive active pharmaceutical ingredients and intermediates.
Your most trusted partner for exclusive synthesis:- More than 150 years experience in process development and production of customized APIs
- Secure and relia... -
Product Highly potent oral solids
Our team has multiple decades of experience offering a wide range of services from development to manufacturing at the highest level of quality compliance. Our technologies include dry and wet granulation processing, blending, capsule filling, tableting, coating, blistering and bottling.
We are ... -
Product Steriles
We are your expert in sterile and aseptic manufacturing, where quality is paramount.
Your most trusted partner for sterile and aseptic fill & finish:
- Extensive knowledge and experience in process and analytical development
- Unbeatable speed to market, without compromising on quality
- ...
Siegfried AG resources (2)
-
News On track at CPHI Barcelona - The Track Sponsor interviews: Siegfried
In our packed out content sessions at CPHI Barcelona this year we focus on some of the hottest topics coming up in the pharma industry, with each track sponsored by a leading expert in the field. -
Webinar From Lab to Commercial Production -How to Combat Challenges in OSD High Potency Products Development
Highly Potent APIs are a rapidly growing segment of the global pharmaceutical industry, and they are acquiring a significant relevance into the development space. The importance to understand the challenges around development of High Potency Oral solids formulations, are the key to ensure a right scale-up and launch Risk-based approach: measuring the risk, not the hazard Challenges for High potency products handling. Importance of select the adequate partner Development of secure and scalable process in high containment environment
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance